Form 4: Towerview LLC disposes 1,973 Gyrodyne shares; holdings 338,107

Rhea-AI Filing Summary

Gyrodyne, LLC (GYRO) Form 4 summary: Towerview LLC reported an insider sale on 09/08/2025. The filing shows a disposition of 1,973 common shares at a price of $12.55 each. After the sale, the reporting person beneficially owns 338,107 common shares. The transaction is coded S (sale) and the ownership form is reported as Direct (D). The Form 4 was signed by Daniel R. Tisch.

Insights

Securities Analyst

TL;DR: Insider sale of 1,973 shares at $12.55 reduced direct holdings to 338,107 shares; routine disclosure with no additional context provided.

The Form 4 documents a straightforward sale transaction by Towerview LLC on 09/08/2025. The sale is recorded under transaction code S and the post-transaction beneficial ownership is reported as 338,107 shares held directly. The filing does not provide reasons for the sale, any associated derivative activity, or link the sale to a trading plan. Given the lack of additional detail, this appears to be a routine insider disposition rather than a material corporate event.

Corporate Governance Expert

TL;DR: Disclosure meets Section 16 reporting requirements; no governance or control change is evident from the filing.

The Form 4 provides the required disclosure of a change in beneficial ownership by a reporting person identified as Towerview LLC and signed by Daniel R. Tisch. The reporting person is indicated as a Director on the form. The filing contains no amendments, no mention of a Rule 10b5-1 plan, and no derivative securities activity. There is no information in the filing that suggests a change in board control, significant ownership shift, or governance action.

Insider Trade Summary

Net Seller: 1,973 shares ($24,761)

Net Sell 1 txn

Insider TOWERVIEW LLC

Role 10% Owner

Sold 1,973 shs ($25K)

Type	Security	Shares	Price	Value
Sale	Common Shares	1,973	$12.55	$25K

Holdings After Transaction: Common Shares — 338,107 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TOWERVIEW LLC

(Last) (First) (Middle)

499 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Gyrodyne, LLC [ GYRO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/08/2025		S		1,973	D	$12.55	338,107	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Daniel R. Tisch	09/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Towerview LLC report for GYRO on 09/08/2025?

The filing reports a sale of 1,973 common shares at $12.55 per share on 09/08/2025.

How many GYRO shares does the reporting person own after the transaction?

The reporting person beneficially owns 338,107 common shares following the reported transaction.

Who filed the Form 4 for this transaction?

The Form 4 was filed by Towerview LLC and signed by Daniel R. Tisch.

Was the transaction executed under a trading plan or is a plan mentioned?

No Rule 10b5-1 plan or other trading plan is mentioned in the filing.

Does the filing show any derivative securities activity?

No. Table II (derivative securities) contains no entries in this filing.